Clinical Trials Logo

Essential Tremor clinical trials

View clinical trials related to Essential Tremor.

Filter by:

NCT ID: NCT03100474 Active, not recruiting - Parkinson's Disease Clinical Trials

Global Registry: ExAblate Neuro MR Guided Focused Ultrasound (MRgFUS) of Neurological Disorders:

Start date: December 2016
Phase:
Study type: Observational [Patient Registry]

A global post approval study to collect safety and effectiveness data related to ExAblate Neuro for the treatment of certain disorders such as Essential Tremor, Parkinson's Movement Disorders, or Neuropathic Pain within the thalamus and/or pallidum.

NCT ID: NCT03074422 Recruiting - Parkinson Disease Clinical Trials

Effectiveness and Reliability of Hypnosis in Stereotaxy

ERST
Start date: July 1, 2017
Phase: N/A
Study type: Interventional

In certain neurosurgical procedures, the use of a stereotaxic frame is required. It is then possible to set a precise target (depending of the type of the surgery) to be reached by the surgeon. The fixation of the stereotactic frame on the awake patient's head is done under local anesthesia by screwing the frame directly into the skull. This procedure is reported as "painful" to "extremely painful" by patients. The objective of this study is to determine whether the hypnosis is effective in decreasing the pain perceived by the patient during the disposal of the stereotactic frame.

NCT ID: NCT03051178 Completed - Essential Tremor Clinical Trials

Wearable Sensor for Responsive DBS for ET

Start date: September 18, 2018
Phase: N/A
Study type: Interventional

The purpose of this study is evaluate the effectiveness and safety of a possible new treatment for Essential Tremor (ET) using external wearable sensors, which have the capability of recording acceleration and Electromyography (EMG). This therapy is called Responsive Deep Brain Stimulation (R-DBS). R-DBS systems will communicate with a computer, and apply stimulation when the computer detects patterns associated with tremor. This detection will suppress pathological activity and improve or alleviate the tremor. Currently, DBS is approved for the treatment of ET; however, stimulation is delivered continuously even when tremor or other symptoms are absent. Continuous DBS can lead to unwanted side effects such as stuttering and gait\balance problems. On the other hand, R-DBS will turn on only if activity associated with ET from the external sensors is detected.

NCT ID: NCT03041714 Completed - Essential Tremor Clinical Trials

Neurophysiologic Study of Patient With Essential Tremor and Dystonic Tremor

Start date: April 7, 2017
Phase:
Study type: Observational

Background: Essential tremor is when a person has tremor, but no other neurological symptoms. Dystonic tremor is when a person also has dystonia. Dystonia is a condition in which muscle contraction causes changes in posture. Researchers do not fully know what areas of the brain cause these tremors, or how the types differ. They also do not know what tests can identify the differences. Objective: To look at differences between essential tremor and dystonic tremor. Eligibility: People ages 18 and older with or without tremor Design: Participants will be screened with medical history, physical exam, and urine tests. Those with tremor will complete questionnaires about how tremor affects them. The screening and study visits can be done on the same day or on separate days. Participants will have 1 or 2 study visits. These include magnetic resonance imaging (MRI) and tremor testing. For MRI, participants will lie on a table that slides in and out of a cylinder that takes pictures. Sensors on the skin measure breathing, heart rate, and muscle activity. This takes about 2 hours. Tremor testing will include transcranial magnetic stimulation (TMS), electrical stimulation of the fingers, doing a movement task, and recording of tremor movements. For TMS, two wire coils will be held on the scalp and a brief magnetic field will be produced. A brief electrical current will pass through the coils. For the other tests, small sticky pad electrodes will be put on the skin. Participants will move their hand when they hear a sound. They will get weak electrical shocks to their fingers. These tests will take 3-4 hours. Participants can take part in either or both parts of the study.

NCT ID: NCT03027310 Completed - Parkinson Disease Clinical Trials

Clinical and Physiological Studies of Tremor Syndromes

Start date: May 5, 2017
Phase:
Study type: Observational

Background: Researchers have some data on how the brain controls movement and why some people have tremor. But the causes of tremor are not fully known. Researchers want to study people with tremor to learn about changes in the brain and possible causes of tremor. Objective: To better understand how the brain controls movement, learn more about tremor, and train movement disorder specialists. Eligibility: People ages 18 and older with a diagnosed tremor syndrome Healthy volunteers ages 18 and older Design: Participants will be screened with: - Medical history - Physical exam - Urine tests - Clinical rating scales - Health questions - They may have electromyography (EMG) or accelerometry. Sensors or electrodes taped to the skin measure movement. Participation lasts up to 1 year. Some participants will have a visit to examine their tremor more. They may have rating scales, EMG, and drawing and writing tests. Participants will be in 1 or more substudies. These will require up to 7 visits. Visits could include the following: - EMG with accelerometry - Small electrodes taped on the body give small electric shocks that stimulate nerves. - MRI: Participants lie on a table that slides into a cylinder that takes pictures of the body while they do simple tasks. - Small electrodes on the scalp record brain waves. - A cone with detectors on the head measures brain activity while participants do tasks. - A wire coil held on the scalp gives an electrical current that affects brain activity. - Tests for thinking, memory, smell, hearing, or vision - Electrodes on the head give a weak electrical current that affects brain activity. - Photographs or videos of movement Participant data may be shared with other researchers.

NCT ID: NCT03025529 Terminated - Essential Tremor Clinical Trials

Transcranial Stimulation for Essential Tremor

Start date: February 2015
Phase: N/A
Study type: Interventional

The main purpose of this study is to see if transcranial magnetic stimulation (TMS) can be used to help study brain function in healthy people and in those with neurological diseases like essential tremor. This portion of the study is being done to establish the optimal methods for stimulating the brain to measure its responses.

NCT ID: NCT02978781 Completed - Essential Tremor Clinical Trials

A Study to Evaluate SAGE-217 in Participants With Essential Tremor

Start date: March 24, 2017
Phase: Phase 2
Study type: Interventional

This study is a three-part, multicenter, Phase 2a study to evaluate the efficacy, safety, tolerability, and pharmacokinetics of SAGE-217 in adult participants with essential tremor.

NCT ID: NCT02960243 Completed - Essential Tremor Clinical Trials

Deep Brain Stimulation for Voice Tremor: Left, Right, or Both Hemispheres?

EVT
Start date: August 2016
Phase: N/A
Study type: Interventional

Deep Brain Stimulation (DBS) is the gold standard treatment for Essential Tremor (ET). ET is a movement disorder which causes the arms, feet, fingers, head or voice to involuntarily shake. The DBS surgical procedure involves implanting an electrode deep within the brain which blocks damaging signals that cause the tremor. Essential Voice Tremor (EVT) is the vocal manifestation of ET and a number of individuals have both ET and EVT, and when these patients are implanted for their ET, their EVT symptoms are often also mitigated. This study aims to quantify the effects of DBS on EVT by testing on these ET+EVT patients. In addition to this, we hope to determine which hemisphere of the brain is responsible for larynx control: left or right.

NCT ID: NCT02947841 Completed - Essential Tremor Clinical Trials

The Effectiveness of Alternating Stimulation in Preventing Tolerance in Essential Tremor Patients

AltStim DBS
Start date: October 2016
Phase: N/A
Study type: Interventional

The purpose of this study is to investigate the hypothesis that alternating DBS parameters on a weekly basis will prevent tolerance to stimulation and thus waning of benefit, compared with non-alternating stimulation. The primary endpoint will be preserved tremor control with the alternating group compared with standard treatment using the Tremor Research Group Essential Tremor Rating Assessment Scale (TETRAS). Key secondary endpoints will be preserved activities of daily living measures as well as preserved tremor control as quantified by motion sensor data. This study has one primary aim: To determine if alternating DBS stimulation parameters on a weekly basis will be superior at preserving tremor control compared with usual stimulation (non-alternating stimulation) in ET patients with VIM DBS.

NCT ID: NCT02909907 Completed - Essential Tremor Clinical Trials

Comparison of Botulinum Toxin Injections in Forearm FLexor Plus EXtensor Muscles vs. Flexor Muscles Alone for Treatment of Essential Hand Tremor(FLEX-D ET)

FLEX-D ET
Start date: August 2016
Phase: N/A
Study type: Interventional

To compare the efficacy of botulinum toxin (BoNT) injections in forearm flexors plus extensor muscles versus flexors alone for the treatment of essential hand tremor (ET).